After years of robust revenue growth fueled by proprietary insecticides and herbicides, FMC Corp suffered steep operating and net losses in fiscal 2025 amid declining prices and operational challenges. The company is executing strategic restructuring including geographic rationalization with asset sales and plant closures, especially in Asia, while advancing innovation around its diamide insecticides and precision ag platform. Capital allocation shows sustained dividends but no buybacks, reflecting constrained cash flow. Key forthcoming milestones include progress on restructuring outcomes and pipeline commercialization that will influence FMC’s ability to recover competitive footing.